FLAMAZINE

This brand name is authorized in Australia, Canada, Hong Kong SAR China, Ireland, New Zealand, Singapore, South Africa, UK.

Active ingredients

The drug FLAMAZINE contains one active pharmaceutical ingredient (API):

1	Silver sulfadiazine UNII W46JY43EJR - SILVER SULFADIAZINE
	Silver sulfadiazine is a sulfonamide and has broad antimicrobial activity against both Gram-positive and Gram-negative organisms including Pseudomonas aeruginosa, some yeasts and fungi. Silver sulfadiazine acts on the cell membrane and cell wall.
	Read more about Silver sulfadiazine

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
FLAMAZINE Cream	MPI, EU: SmPC	Medicines and Medical Devices Safety Authority (NZ)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
D06BA01	Silver sulfadiazine	D Dermatologicals → D06 Antibiotics and chemotherapeutics for dermatological use → D06B Chemotherapeutics for topical use → D06BA Sulfonamides
Discover more medicines within D06BA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	9479X
CA	Health Products and Food Branch	00323098
GB	Medicines & Healthcare Products Regulatory Agency	34458, 34459, 34460
HK	Department of Health Drug Office	08615
IE	Health Products Regulatory Authority	79537, 79545, 79553
NZ	Medicines and Medical Devices Safety Authority	13877, 13878
SG	Health Sciences Authority	04671P
ZA	Health Products Regulatory Authority	H/14.2/3003